ASTX727 and Nivolumab in Squamous Cell Carcinoma of the Head and Neck
Conditions: Recurrent Squamous Cell Carcinoma of the Head and Neck; Metastatic Squamous Cell Carcinoma; Head and Neck Squamous Cell Carcinoma Interventions: Drug: INQOVI (decitabine and cedazuridine); Drug: Nivolumab Sponsors: Case Comprehensive Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Head and Neck Cancer | HNSCC | Research | Skin Cancer | Squamous Cell Carcinoma